M F Linton Selected Research

Apolipoproteins

12/2001	Isoform-specific effects of apolipoprotein E on atherogenesis: gene transduction studies in mice.
11/2001	Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice.
10/2001	Class A scavenger receptors, macrophages, and atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M F Linton Research Topics

Disease

11	Atherosclerosis 01/2013 - 03/2000
5	Hyperlipidemias (Hyperlipidemia) 10/2001 - 03/2000
4	Inflammation (Inflammations) 01/2013 - 01/2000
3	Coronary Disease (Coronary Heart Disease) 03/2012 - 01/2000
2	Insulin Resistance 01/2013 - 05/2001
2	Hypercholesterolemia 03/2000 - 01/2000
1	Kidney Diseases (Kidney Disease) 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2013
1	Hyperuricemia 05/2012
1	Obesity 03/2012
1	Chronic Disease (Chronic Diseases) 03/2012
1	Hypertrophy 05/2001
1	Proteinuria 05/2001
1	Sclerosis 05/2001
1	Carotid Stenosis (Carotid Artery Stenosis) 05/2001
1	Atherosclerotic Plaque (Atheroma) 03/2001
1	Xanthomatosis (Xanthoma) 03/2000
1	Thrombosis (Thrombus) 01/2000
1	Dyslipidemias (Dyslipidemia) 01/2000
1	Hypertriglyceridemia 01/2000

Drug/Important Bio-Agent (IBA)

6	CholesterolIBA 01/2013 - 01/2000
6	LDL Receptors (LDL Receptor)IBA 10/2001 - 03/2000
5	Apolipoproteins E (ApoE)IBA 12/2001 - 03/2000
4	Lipoproteins (Lipoprotein)IBA 10/2001 - 01/2000
3	ApolipoproteinsIBA 12/2001 - 10/2001
3	LipidsIBA 07/2001 - 03/2001
2	Triglycerides (Triacylglycerol)IBA 01/2013 - 01/2000
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2001 - 09/2001
2	Scavenger Receptors (Scavenger Receptor)IBA 10/2001 - 12/2000
2	Sterol O-AcyltransferaseIBA 01/2001 - 03/2000
1	AngiotensinsIBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2013
1	CytokinesIBA 01/2013
1	CalciumIBA 01/2013
1	ORALIT (ORS)IBA 05/2012
1	purineIBA 05/2012
1	Uric Acid (Urate)IBA 05/2012
1	Proteins (Proteins, Gene)FDA Link 05/2012
1	C-Reactive ProteinIBA 03/2012
1	Biomarkers (Surrogate Marker)IBA 03/2012
1	Apolipoprotein E3IBA 12/2001
1	Protein Isoforms (Isoforms)IBA 12/2001
1	Class A Scavenger ReceptorsIBA 10/2001
1	HDL CholesterolIBA 09/2001
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2001
1	Troglitazone (Rezulin)FDA Link 05/2001
1	PPAR-gamma AgonistsIBA 05/2001
1	CreatinineIBA 05/2001
1	Glucose (Dextrose)FDA LinkGeneric 05/2001
1	Insulin (Novolin)FDA Link 05/2001
1	LigandsIBA 05/2001
1	Plasminogen Activator Inhibitor 1IBA 05/2001
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2001
1	PPAR gammaIBA 05/2001
1	Apolipoproteins B (ApoB)IBA 03/2001
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2001
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2001
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 08/2000
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2000
1	Oxidoreductases (Dehydrogenase)IBA 01/2000
1	HDL LipoproteinsIBA 01/2000
1	Fibric Acids (Fibrates)IBA 01/2000
1	oxidized low density lipoproteinIBA 01/2000

Therapy/Procedure

3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2001 - 03/2000